United States

Abbott CFO says Alere is expected to contribute around $475 mln to reported sales this year

Wednesday, 18 Oct 2017 10:41am EDT 

Oct 18 (Reuters) - Abbott Laboratories :Abbott CFO says Alere, is expected to contribute around $475 million to reported sales, and forecast a neutral impact on adjusted earnings per share this year - Conf Call.Abbott CFO expects fourth quarter adjusted earnings per share of $0.72 to $0.74 - Conf Call.Abbott CFO expects Q4 comparable operational sales growth in the mid to high single-digits - Conf Call.Abbott CFO says "established pharmaceuticals, we forecast double-digit sales growth and in nutrition, we forecast low single-digit sales growth" in Q4 - Conf Call.Abbott CFO says "in diagnostics, we forecast sales to increase mid single-digits and in medical devices, we forecast sales to increase mid to high single-digits in Q4" - Conf Call.Abbott CEO on China nutrition business says "we've seen a stabilizing of China, it hasn't been as choppy as it was in the last 2 years".